Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes - Jimenez-Solem, E; Rasmussen, M H; Christensen, M (Curr Opin Mol Ther, 2010)
et al